Overview
- 4 inspections across 4 sites are on record.
- 15 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-10-08.
At a glance
Inspections
4
Sites
4
Observations
15
Career since
Feb 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| InfuScience, Inc. dba Bioscrip Infusion Services | 8 Oct 2021 | Human Drugs | View 483 → |
| Inopak Ltd | 18 Jun 2021 | Human Drugs | View 483 → |
| SpecGx LLC | 13 Mar 2020 | Human Drugs | |
| Jubilant Cadista Pharmaceuticals, Inc. | 28 Feb 2020 | Human Drugs | View 483 → |
Sites inspected
InfuScience, Inc. dba Bioscrip Infusion ServicesChantilly, United States1 insp.
Inopak LtdRingwood, United States1 insp.
SpecGx LLCHobart, United States1 insp.
Jubilant Cadista Pharmaceuticals, Inc.Salisbury, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Roseline N Boateng2 shared
Juanita P Versace1 shared
Sena G Dissmeyer1 shared
William J Leonard1 shared
Marcus A Ray1 shared
Sony Mathews1 shared
Full investigator report
Get the verbatim findings behind Marcia D Fields' 15 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site